Tumor treating fields (TTFields) concomitant with PARP inhibitors or carboplatin for treatment of ovarian cancer cell lines

被引:0
|
作者
Martinez-Conde, Antonia
Ene, Hila
Frechtel-Gerzi, Roni
Dor-On, Eyal
Haber, Adi
Giladi, Moshe
Weinberg, Uri
Palti, Yoram
机构
关键词
D O I
10.1158/1538-7445.AM2023-6182
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6182
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Tumor Treating Fields (TTFields) Concomitant with PARP Inhibitors for Treatment of Ovarian Cancer Cell Lines
    Martinez-Conde, A.
    Frechtel-Gerzi, R.
    Ene, H.
    Dor-On, E.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E276 - E276
  • [2] Concomitant treatment of ovarian cell lines with Tumor Treating Fields (TTFields) and PARP inhibitors
    Martinez-Conde, Antonia
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Preclinical efficacy of Tumor Treating Fields (TTFields) applied with PARP inhibitors or carboplatin in ovarian cancer
    Martinez-Conde, Antonia
    Ene, Hila
    Ben-Meir, Kerem
    Frechtel-Gerzi, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (01)
  • [4] Preclinical effects of Tumor Treating Fields (TTFields) with PARP inhibitors in ovarian cancer
    Berckmans, Yani
    Ene, Hila
    Ben-Meir, Kerem
    Martinez-Conde, Antonia
    Monin, Roni
    Van den Ende, Bieke
    Van Mechelen, Sara
    Frechtel-Gerzi, Roni
    Gabay, Hila
    Engelman, Rotem
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    Vergote, Ignace
    Coosemans, An
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Efficacy of combining tumor treating fields (TTFields) with a PARP inhibitor in ovarian cell lines
    Mulvey, Brett
    Martinez-Conde, Antonia
    Efimov, Vera
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S158 - S158
  • [6] Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
    Ene, Hila
    Ben Meir, Kerem
    Martinez-Conde, Antonia
    Frechtel-Gerzi, Roni
    Gabay, Hila
    Gerasimova, Daria
    Engelman, Rotem
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Tumor Treating Fields (TTFields) together with PARP inhibitors for treatment of pancreatic cancer cells
    Martinez-Conde, Antonia
    Ene, Hila
    Ben-Meir, Kerem
    Dor-On, Eyal
    Lamichhane, Puru
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (02)
  • [8] Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
    Vergote, Ignace
    Macarulla, Teresa
    Hirsch, Fred R.
    Hagemann, Carsten
    Miller, David Scott
    CANCERS, 2023, 15 (03)
  • [9] Treatment of gastric cancer cells with tumor treating fields (TTFields) and concomitant FOLFOX
    Flint-Brodsly, Naama
    Zeevi, Einav
    Wainer-Katsir, Kerem
    Fishman, Hila
    Martinez-Conde, Antonia
    Dor-On, Eyal
    Munster, Mijal
    Porat, Yaara
    Voloshin, Tali
    Davidi, Shiri
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2023, 83 (07)
  • [10] THE EFFICACY OF TEMOZOLOMIDE AND LOMUSTINE IN GLIOBLASTOMA CELL LINES MAY BE ENHANCED BY CONCOMITANT TREATMENT WITH TUMOR TREATING FIELDS (TTFIELDS)
    Fishman, Hila
    Monin, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2022, 24 : 92 - 92